Both fecal and blood microbiota profiles showed different patterns between participants with obese-type versus lean-type nonalcoholic fatty liver disease (NAFLD), and these may serve as diagnostic biomarkers to differentiate diverse phenotypes of this rapidly growing health problem, according to South Korean researchers.